Pharmacy Management
Prescription drugs are the fastest growing component of healthcare costs. These costs can be prohibitive, requiring employers to change plan designs and shift even more cost to their employees. This is particularly true for specialty medications that typically represent 50% of drug spend from just 1-2% of drug utilizers.
Unfortunately, many employers don’t have the purchasing power or market leverage to negotiate better pricing. It’s also challenging for employers to identify and access money saving opportunities.
Our Alera Group Pharmacy Solutions practice has a dedicated team of experienced, in-house Pharmacy Benefits Management experts. They offer a full range of pharmacy consulting services, including:
- Prescription drug program evaluations for clients of all sizes and industries
- Comprehensive RFP management renewal, market check and RFI
- PBM contract review and negotiation
- Consultative support to identify and deploy unique cost-mitigation for specialty drug solutions
- Data analytics that enable precise financial and clinical pharmacy benefits consulting and reporting, maximizing the plan value and employee dollars
- All forms of pharmacy benefits auditing, including PBM contract pricing, plan design and clinical
- On-going risk management and cost containment under our Rx Concierge Program
With Alera Group, you have a local partner and a team of experts you can rely on to help you manage pharmacy costs and improve your outcomes today and in the future.
Our Alera Group Pharmacy Solutions experts are backed by leading-edge tools and strategic solutions focused on meeting the needs and expectations of our clients through every stage of the pharmacy process.
Control pharmacy costs
From procurement to prescriptions.
EXPERT EDUCATION
Events and Webinars
Employee Benefits
The Compliance Pathway Q1
Alera Group's quarterly employee benefits compliance roundup will help you stay current on the latest national regulatory developments impacting employers.
March 5, 2026 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
PBM Accountability: Why Employers Overpay — and How to Enforce Transparency
A PBM oversight model with accountability built in.
May 19, 2026 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
GLP-1s at Scale: Why Weight-Loss Drug Decisions Are Now a Financial Strategy
A GLP-1 decision framework plus scenarios.
July 21, 2026 at 01:00 pm CT | Virtual
Sign Up
THOUGHT LEADERSHIP
Insights
Employee Benefits
Legal Alert: RxDC Reporting Due June 1st
Reminder: RxDC Reporting Due June 1st
February 26, 2026
Find out moreEmployee Benefits
IRS Releases Guidance Related to Recent HSA Changes
The IRS recently released Notice 2026-5, which provides guidance and answers to common questions related to the expanded availability of health savings accounts (“HSA”) under the Reconciliation Act (previously named the One Big Beautiful Bill Act) passed into law earlier this year.
December 30, 2025
Find out moreEmployee Benefits
Legal Alert: RxDC Reporting Due June 1
Reminder: RxDC Reporting Due June 1
With the 2023 reference year RxDC reporting deadline approaching soon, plan sponsors should familiarize themselves with recent updates to the RxDC Reporting Instructions.
March 27, 2024
Find out moreEmployee Benefits
Webinar: Weight-Loss Drugs and Group Health Plans | Alera Group
Rising pharmacy costs are among the chief drivers of healthcare expenses for employers and employees, thanks largely to a surge in use of drugs you’ve seen advertised in those ubiquitous commercials. Given the cost of such drugs and their mixed record of success, employers and employees should exercise caution.
February 6, 2024
Find out more